🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchClinicalTrials.gov GLP-1 trial tracker — updated weekly Page 5

ClinicalTrials.gov GLP-1 trial tracker — updated weekly

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 411 replies 11,865 viewsPage 5 of 20
PurityPaulOR
Senior Member
1,890
7,890
Mar 2024
Oregon
Mar 19, 2024 at 7:25 PM#21
DoseLogDan said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

Correct as far as it goes. The part it does not cover is what to do when the honest answer is "not enough data", which is more often than anyone likes.

28 1Dr.LeslieOBGYN, MikeNYC_runner and 25 others
Reply Quote Save Share Report
SaraMom3
Member
456
2,345
Aug 2024
Ohio
Mar 28, 2024 at 10:02 AM#22
DoseLogDan said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

This answered a question I did not know how to ask. Printing the relevant bit and taking it with me.

29 2ChrisMacros, KetoKyle, CanadaChris and 26 others
Reply Quote Save Share Report
claudia_zurich
Member
389
1,678
Jul 2024
Zurich, CH
Apr 6, 2024 at 12:34 AM#23

From the other side of the consultation, briefly. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

Last edited: Apr 6, 2024 at 6:34 AM
30 3Dr.LipidDallas, alex_tucson, kevin_tulsa and 27 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
Apr 14, 2024 at 3:01 PM#24
claudia_zurich said:
The mechanism and the magnitude are separate questions.

Same experience, arrived at from the opposite direction. I had assumed I was the exception until I read this.

Last edited: Apr 14, 2024 at 4:01 PM
31 4DebRD_ATL, KristenIndy, MarkLI_maint and 28 others
Reply Quote Save Share Report
SallyK_inj
Member
567
2,345
Jul 2024
Iowa
Apr 23, 2024 at 5:23 AM#25
claudia_zurich said:
The mechanism and the magnitude are separate questions.

There is a second half to this that has not been said yet. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

32 5Dr.PathRoch, mona_PHX, andrew_nyc and 29 others
Reply Quote Save Share Report
13456720

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register